CVRx, Inc.
Clinical trials sponsored by CVRx, Inc., explained in plain language.
CVRx, Inc.
CVRX
NASDAQ
A medical device company developing neuromodulation therapies for cardiovascular diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- A neck implant aims to quiet Hard-to-Treat high blood pressure Results expected Jul 2027 (estimated)
- Nerve-stimulating implant tested for easing heart failure symptoms Results expected Jul 2027 (estimated)